Antigeenpresentatie  bij SARS-CoV-2-infectie

Antigeenpresentatie  bij SARS-CoV-2-infectie: de rol van klasse I HLA- en ERAP-polymorfismen

Gezien de zeer polymorfe aard van humaan leukocytenantigeen (HLA)-moleculen, is het niet verwonderlijk dat ze fungeren als belangrijke regulatoren van de immuunrespons van de gastheer op bijna alle binnendringende pathogenen, waaronder SARS-CoV-2 , het etiologische agens dat verantwoordelijk is voor de recente COVID-19 -19 pandemie. Er zijn al verschillende correlaties vastgesteld tussen de expressie van een specifiek HLA-allel/haplotype en gevoeligheid/progressie van SARS-CoV-2-infectie en er komen voortdurend nieuwe bij. Beschermende en schadelijke HLA-varianten zijn beschreven in zowel milde als ernstige vormen van de ziekte, maar gezien de enorme hoeveelheid bestaande varianten zijn de gegevens die in zo’n korte tijdspanne zijn verzameld tot op zekere hoogte verwarrend en tegenstrijdig.

Het doel van deze mini-review is om een ​​momentopname te geven van de belangrijkste bevindingen die tot nu toe zijn verzameld over de HLA-SARS-CoV-2-interactie, om dit ingewikkelde garen gedeeltelijk te ontwarren. Als sleutelfactoren bij het genereren van antigene peptiden die door HLA-moleculen moeten worden gepresenteerd , zal ook de rol van ERAP1 en ERAP2 bij SARS-CoV-2-infectie worden herzien.

Beoordeling van immunogeniciteit en veiligheid in twee productiepartijen van een 3- antigeen  hepatitis B-vaccin, Sci-B-Vac®, vergeleken met Engerix-B® bij gezonde Aziatische volwassenen: een gerandomiseerde klinische fase 3-studie

Achtergrond:  Sci-B-Vac®, een 3-antigeen hepatitis B-vaccin (3A-HBV), bevat alle drie de envelopeiwitten van het recombinante hepatitis B-virus (HBV) (S, pre-S1 en pre-S2). In 2005 verplaatste de productie van 3A-HBV de faciliteiten (A naar B), waar het nog steeds wordt geproduceerd.

Methoden:  Deze fase 3, enkelblinde, gerandomiseerde studie, uitgevoerd op één locatie in Vietnam, vergeleek de werkzaamheid en veiligheid tussen twee 3A-HBV-partijen, partij A en partij B, en een enkel antigeen hepatitis B-vaccin (1A-HBV) , Engerix-B®. Het primaire doel was om op dag 210 gelijkwaardigheid aan te tonen van twee 3A-HBV-lots in seroprotectiepercentage (SPR; gedefinieerd als proportion deelnemers dat hepatitis B-oppervlakteantigeenantilichaam [anti-HBs]-titers ≥ 10 mIU/ml bereikte). Secundaire doelstellingen waren het beoordelen van de immunogeniciteit op dag 180, 210 en 360, en de veiligheid van 3A-HBV.

Resultaten:  3A-HBV SPR-equivalentie werd aangetoond op dag 210 (partij A: 97,3% [95% BI: 92,4%, 99,4%] vs. partij B: 100,0% [97,0%, 100,0%]). Vergeleken met 1A-HBV was de SPR van partij B hoger op dag 180 (98,3% vs. 81,2%; verschil: 17,1% [9,7%, 24,6%]) en niet-inferieur op dag 210 (100% vs. 98,3%; verschil : 1,7% [-0,6%, 4,1%]). 3A-HBV partij B vertoonde dezelfde SPR na 2 doses (98,3%) als 1A-HBV na Three doses (98,3%). Bijwerkingen (AE’s) waren vergelijkbaar met beide 3A-HBV-partijen (partij A: 68,7% vs. partij B: 54,2%), maar hoger dan 1A-HBV (35,3%). Vaccinatiegerelateerde bijwerkingen omvatten voorbijgaande pijn op de injectieplaats (38,9%), myalgie (9,3%) en vermoeidheid (7,5%). Er werden acht ernstige bijwerkingen gemeld (partij A: 3/134 [2,2%]; partij B: 1/134 [0,8%]; 1A-HBV: 4/133 [2,3%]). Eén ernstige AE, syncope, werd opgemerkt als waarschijnlijk gerelateerd aan onderzoeksvaccin, lot B.

Conclusies:  De twee 3A-HBV-partijen hadden een gelijkwaardige immunogeniciteit, maar partij B veroorzaakte een snellere aanvang van seroprotectie en hogere anti-HBs-titers dan zowel partij A als 1A-HBV in een Aziatische populatie. Dit ondersteunt 3A-HBV lot B als een effectieve keuze voor HBV-vaccinatie, met een gunstig veiligheidsprofiel.

robegids
robegids

Influenza A Virus H1 Antigen Antibody

abx415739-200l 200 µl
EUR 650

NATIVE INFLUENZA A ANTIGEN

GWB-1779A2 1 ml Ask for price

Influenza A (H1N1) Antigen

11-553 1 mL
EUR 645
Description: Influenza A, Influenza A (H1N1)

Influenza A (H3N2) Antigen

11-554 1 mL
EUR 645
Description: Influenza A Antigen Strain TX, Influenza A Antigen Strain Texas

Influenza A H1N1 Antigen

abx670268-1ml 1 ml
EUR 627.6

Influenza A H1N1 Antigen

abx670268-100g 100 µg
EUR 437.5

Influenza A H3 Antibody

abx021977-1mg 1 mg
EUR 1053.6

Influenza A H3 Antibody

abx021978-1mg 1 mg
EUR 1053.6

Influenza A H3 Antibody

abx021977-400l 400 µl Ask for price

Influenza A H3 Antibody

abx021977-80l 80 µl
EUR 975

Influenza A H3 Antibody

abx021978-400l 400 µl Ask for price

Influenza A H3 Antibody

abx021978-80l 80 µl
EUR 975

Influenza A Virus Nucleoprotein Antibody (HL1089)

MAB12483-100 0.1
EUR 529.44
Description: Anti-influenza A virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza A Virus Nucleoprotein Antibody (HL1089)

MAB12483-500 0.5
EUR 2261.91
Description: Anti-influenza A virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza A Virus Nucleoprotein Antibody (HL1103)

MAB12484-100 0.1
EUR 529.44
Description: Anti-influenza A virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza A Virus Nucleoprotein Antibody (HL1103)

MAB12484-500 0.5
EUR 2261.91
Description: Anti-influenza A virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza A Virus Nucleoprotein Antibody (HL1078)

MAB12485-100 0.1
EUR 529.44
Description: Anti-influenza A virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza A Virus Nucleoprotein Antibody (HL1078)

MAB12485-500 0.5
EUR 2261.91
Description: Anti-influenza A virus nucleoprotein monoclonal antibody, made in rabbit.

Mouse Anti Influenza A H5 Antigen Monoclonal Antibody

DMABT-51386MI 0.2 mg
EUR 795.6

Mouse Anti Influenza A H5 Antigen Monoclonal Antibody

DMABT-51388MI 0.2 mg
EUR 889.2

Influenza A Virus Antigen (H5N1)

VAng-Lsx011-1mL 1 mL
EUR 883.2
Description: Natural antigen of Influenza A virus subtype H5N1.

Influenza A (H1N1) Antigen Liquid

IFLUAH1N1ALR1ML each
EUR 771
Description: Influenza A (H1N1) Antigen Liquid

Influenza A (H3N2) Antigen Liquid

IFLUAH3N2ALR1ML each
EUR 754
Description: Influenza A (H3N2) Antigen Liquid

NATIVE INFLUENZA A H1N1 ANTIGEN

GWB-B63944 1 ml Ask for price

Influenza A (H3N2) Antigen Protein

abx061421-1ml 1 ml
EUR 718.8

Influenza A (H3N2) Antigen Protein

abx061421-100g 100 µg Ask for price

Influenza A (H3N2) Antigen Protein

abx061421-10g 10 µg
EUR 862.5

Influenza A (H3N2) Antigen Protein

abx061421-50g 50 µg Ask for price

Influenza B Antigen

abx670262-1ml 1 ml
EUR 510

Influenza B Antigen

abx670262-100g 100 µg
EUR 337.5

OOSA09775-1ML - NATIVE INFLUENZA A H1N1 ANTIGEN Antigen

OOSA09775-1ML 1ml
EUR 549

NATIVE INFLUENZA B ANTIGEN

GWB-E9EC80 1 ml Ask for price

OPEF01452-1ML - Influenza A Virus Antigen

OPEF01452-1ML 1ml
EUR 347

Influenza B Virus Nucleoprotein Antibody (HL1068)

MAB12480-100 0.1
EUR 529.44
Description: Anti-influenza B virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza B Virus Nucleoprotein Antibody (HL1068)

MAB12480-500 0.5
EUR 2261.91
Description: Anti-influenza B virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza B Virus Nucleoprotein Antibody (HL1069)

MAB12481-100 0.1
EUR 529.44
Description: Anti-influenza B virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza B Virus Nucleoprotein Antibody (HL1069)

MAB12481-500 0.5
EUR 2261.91
Description: Anti-influenza B virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza B Virus Nucleoprotein Antibody (HL1073)

MAB12482-100 0.1
EUR 529.44
Description: Anti-influenza B virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza B Virus Nucleoprotein Antibody (HL1073)

MAB12482-500 0.5
EUR 2261.91
Description: Anti-influenza B virus nucleoprotein monoclonal antibody, made in rabbit.

Influenza A Strain A/Kiev/301/94 (H3N2) Antigen

11-568 0.1 mg
EUR 632.4
Description: Influenza A (A/Kiev/301/94) (H3N2), Influenza Virus Type A (H3N2), Strain A/Kiev/301/94

Influenza A Strain A/Panama/2007/99 (H3N2) Antigen

11-570 0.05 mg
EUR 632.4
Description: Influenza A (A/Panama/2007/99) (H3N2), Influenza Virus Type A (H3N2), Strain A/Panama/2007/99

OOSA09766-1ML - NATIVE INFLUENZA B ANTIGEN Antigen

OOSA09766-1ML 1ml
EUR 299

Influenza A Strain A/Beijing/262/95 (H1N1) Antigen

11-566 0.1 mg
EUR 632.4
Description: Influenza A (A/Beijing/262/95), Influenza Virus, Type A (H1N1), Strain A/Beijing/262/95

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen

11-567 0.1 mg
EUR 632.4
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2)

Recombinant Avian influenza Antigen

E41H050 100ug
EUR 395

Influenza A Strain A/Shangdong/9/93 (H3N2) Antigen

11-571 0.1 mg
EUR 632.4
Description: Influenza A (A/Shangdong/9/93) (H3N2), Influenza Virus, Type A, Strain A/Shangdong/9/93, (H3N2)

Influenza A Strain A/Wisconsin/67/05 (H3N2) Antigen

11-573 0.1 mg
EUR 632.4
Description: Influenza A (A/Wisconsin), Influenza A Virus, Strain A/Wisconsin/67/05 (H3N2)

Influenza A Strain A/Kiev/301/94 (H3N2) Antigen Liquid

IFLUAKV30194H3N2ALR100UG each
EUR 738
Description: Influenza A Strain A/Kiev/301/94 (H3N2) Antigen Liquid

Recombinant Avian influenza H5 Antigen

E41H045 100ug
EUR 395

Recombinant Avian influenza H9 Antigen

E41H046 100ug
EUR 395

Influenza A Strain A/Panama/2007/99 (H3N2) Antigen Liquid

IFLUAPNA200799H3N2ALR50UG each
EUR 738
Description: Influenza A Strain A/Panama/2007/99 (H3N2) Antigen Liquid

Influenza A Strain A/Beijing/262/95 (H1N1) Antigen Liquid

IFLUABJ26295H1N1ALR100UG each
EUR 738
Description: Influenza A Strain A/Beijing/262/95 (H1N1) Antigen Liquid

Influenza A [A/Brisbane/59/2007 (H1N1)] Viral Lysate

NAT41628-100 0.1
EUR 512.85
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A Strain A/Solomon Islands/03/06 (H1N1) Antigen

11-572 0.1 mg
EUR 632.4
Description: Influenza A (A/Solomon Island), Influenza A Strain A/Solomon Islands/03/06 (H1N1)

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

IFLUABN1007H3N2ALR100UG each
EUR 738
Description: Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

Influenza A Strain A/Shangdong/9/93 (H3N2) Antigen Liquid

IFLUASHDG993H3N2ALR100UG each
EUR 738
Description: Influenza A Strain A/Shangdong/9/93 (H3N2) Antigen Liquid

Influenza A Strain A/Wisconsin/67/05 (H3N2) Antigen Liquid

IFLUAWI6705H3N2ALR100UG each
EUR 738
Description: Influenza A Strain A/Wisconsin/67/05 (H3N2) Antigen Liquid

Human Influenza A/B Virus Antigen Rapid Test Kit

abx090713-100l 100 µl
EUR 650

Human Influenza A/B Virus Antigen Rapid Test Kit

abx090713-1ml 1 ml
EUR 10500

Human Influenza A/B Virus Antigen Rapid Test Kit

abx090713-200l 200 µl
EUR 2100

Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate

NAT41641-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate

NAT41641-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate

NAT41634-100 0.1
EUR 512.85
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate

NAT41634-500 0.5
EUR 2181.53
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate

NAT41629-100 0.1
EUR 512.85
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate

NAT41629-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test

ISIN-525H 25 Tests
EUR 18.75

Influenza A antibody

10-1096 500 ug
EUR 165
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1097 1 mg
EUR 295
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1098 1 mg
EUR 532
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1099 1 mg
EUR 532
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1101 1 mg
EUR 532
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1102 500 ug
EUR 295
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1103 500 ug
EUR 295
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1241 500 ug
EUR 149
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1243 500 ug
EUR 149
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-7866 1 mg
EUR 345
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-7867 1 mg
EUR 345
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50A 1 mg
EUR 150
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50B 1 mg
EUR 335
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50C 1 mg
EUR 603
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50D 1 mg
EUR 231
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50E 1 mg
EUR 231
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50F 1 mg
EUR 225
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50G 1 mg
EUR 425
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50H 1 mg
EUR 425
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50I 1 mg
EUR 425
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50K 1 mg
EUR 225
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50L 1 mg
EUR 250
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50M 1 mg
EUR 250
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50N 1 mg
EUR 250
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50O 1 mg
EUR 250
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50P 1 mg
EUR 250
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50Q 1 mg
EUR 225
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50R 1 mg
EUR 225
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50S 1 mg
EUR 225
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50T 1 mg
EUR 225
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50U 1 mg
EUR 225
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1100 500 ug
EUR 295
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10R-I131a 1 mg
EUR 413
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10R-I131b 1 mg
EUR 425
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10C-CR1306M1 100 ug
EUR 425
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10C-CR1306M2 100 ug
EUR 95
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

70R-IR080 100 ug
EUR 295
Description: Affinity purified Rabbit polyclonal Influenza A antibody

Influenza A antibody

70R-IR082 100 ug
EUR 280
Description: Affinity purified Rabbit polyclonal Influenza A antibody

Influenza A, Antibody

GWB-3C6881 1 mg Ask for price

Influenza A Antibody

GWB-3E7255 1 ml Ask for price

Influenza A, Antibody

GWB-438D7C 1 mg Ask for price

Influenza A, Antibody

GWB-4A751E 1 mg Ask for price

Influenza A, Antibody

GWB-5D1AF3 1 mg Ask for price

Influenza A Antibody

GWB-226212 1 ml Ask for price

Influenza A Antibody

GWB-8071AA 0.2 mg Ask for price

Influenza A Antibody

GWB-8A3BB6 1 ml Ask for price

Influenza A Antibody

GWB-8CCFC3 1 ml Ask for price

Influenza A, Antibody

GWB-8E031F 1 mg Ask for price

Influenza A Antibody

GWB-A2EB59 1 ml Ask for price

Influenza A Antibody

GWB-AC36F0 1 ml Ask for price

Influenza A Antibody

GWB-7ACE73 0.1 ml Ask for price

Influenza A, Antibody

GWB-F2522F 1 mg Ask for price

Influenza A, Antibody

GWB-B5C2F5 1 mg Ask for price

Influenza A Antibody

GWB-BAB424 1 ml Ask for price

Influenza A, Antibody

GWB-BB42AF 1 mg Ask for price

Influenza A Antibody

GWB-BC07CC 1 ml Ask for price

Influenza A, Antibody

GWB-E12D5B 1 mg Ask for price

Influenza A Antibody

GWB-C7F98B 1 ml Ask for price

Influenza A Antibody

GWB-CE07D4 0.1 ml Ask for price

Influenza A, Antibody

GWB-CE9581 1 mg Ask for price

Influenza A Antibody

GWB-D66016 1 ml Ask for price

Influenza A, Antibody

GWB-C32B59 1 mg Ask for price

Influenza B Antibody (Hemagglutinin H3)

GWB-T00319 1 mg Ask for price

Influenza B Antibody (Hemagglutinin H3)

GWB-T00327 1 mg Ask for price

Avian Influenza A Nucleoprotein Antigen Capture ELISA Kit

DEIA2026 2 x 96T
EUR 1554
Description: This kit is a highly sensitive and specific enzyme immunoassay for the detection of Influenza A nucleoprotein antigen in complex sample matrices derived from both human and veterinary sources.

Influenza A Strain A/New Caledonia/20/99 IVR 116 (H1N1) Antigen

11-569 0.1 mg
EUR 632.4
Description: Influenza A (A/New Caledonia), Influenza Virus, Type A (H1N1), Strain A/New Caledonia/20/99 IVR116

Influenza A Strain A/Solomon Islands/03/06 (H1N1) Antigen Liquid

IFLUASOIS0306H1N1ALR100UG each
EUR 738
Description: Influenza A Strain A/Solomon Islands/03/06 (H1N1) Antigen Liquid

Influenza A [A/Ohio/12/2017 (H3N2)] Neuraminidase (NA), His-tag

REC31914-100 0.1
EUR 355.94
Description: Influenza virus A H3N2 virus neuraminidase (NA) was expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and dialysis.

Influenza A [A/Ohio/12/2017 (H3N2)] Neuraminidase (NA), His-tag

REC31914-500 0.5
EUR 1247.68
Description: Influenza virus A H3N2 virus neuraminidase (NA) was expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and dialysis.

Influenza A G4 EA (H1N1) Nucleoprotein (NP), His-Tag

REC31964-100 0.1
EUR 311.28
Description: Recombinant influenza A swine G4 reassortant nucleoprotein.

Influenza A G4 EA (H1N1) Nucleoprotein (NP), His-Tag

REC31964-500 0.5
EUR 1182.63
Description: Recombinant influenza A swine G4 reassortant nucleoprotein.

Influenza A (NP) Antibody

abx023634-1mg 1 mg
EUR 718.8

Op glasplaatjes gedrukte eiwitarrays als platform om serodiagnostische antigenen  tegen bacteriële infecties te ontdekken

Infectieziekten vormen wereldwijd een belangrijke oorzaak van morbiditeit en mortaliteit. Vroege opsporing van infecties is van cruciaal belang voor het beheer van levensbedreigende gevallen . Tot nu toe zijn traditionele diagnostische methoden, zoals microbiologische culturen, traag en soms onnauwkeurig. In het moleculaire tijdperk zijn high-throughput-technieken essentieel voor het leveren van hulpmiddelen die in staat zijn om op een snelle en betrouwbare manier een diagnose te stellen, en ze kunnen ook worden gebruikt voor het bewaken van de humorale respons van groepen mensen in een programma van epidemiologische surveillance wanneer een uitbraak plaatsvindt, of wanneer een vaccin wordt geëvalueerd. Op antigeen gebaseerde eiwitmicroarrays zijn een ideaal middelvoor deze doeleinden, aangezien ze tot duizenden eiwitantigenen van pathogene bronnen kunnen dragen en kunnen worden onderzocht met sera van verschillende menselijke groepen (acute of chronisch geïnfecteerde mensen, herstellende, controles).

Voor de diagnose van bacteriële infecties zijn de beste antigenen in principe de oppervlakte-eiwitten, omdat deze de grootste kans hebben om een ​​effectieve immuunrespons op te wekken. Hier beschrijven we een algemeen protocol voor het fabriceren van een op glasplaatjes gebaseerde eiwitmicroarray met behulp van recombinante bacteriële oppervlakteantigenen, volgens onze eigen experience in de studie van pneumokokkenziekte. Het sonderen met menselijke sera heeft tot doel de verschillen tussen zieke en gezonde mensen te evalueren , om onderscheidende antigenen te ontdekken die, na gepaste validatie, kunnen worden gebruikt in andere gebruiksvriendelijke formaten zoals immunostrips.

Antigeen- presenterende, zelf-geassembleerde eiwit-nanovaten als een adjuvans-vrij vaccinplatform tegen het influenzavirus

Hoewel ze van nature voorkomen, zijn zelf-geassembleerde eiwit-nanoarchitecturen gebruikt als dragers voor het afleveren van antigeen, en het onvermogen van dergelijke dragers om immunogeniciteit op te wekken vereist aanvullend gebruik van sterke adjuvantia. Hier rapporteren we een immunogene  Brucella-  buitenmembraaneiwit BP26-afgeleide nanoarchitectuur die het extracellulaire influenzadomein van matrixproteïne-2 (M2e) als een vaccinplatform tegen influenzavirus weergeeft. Genetische manipulatie van een monomeer BP26 met vier of acht tandemherhalingen van M2e resulteerde in een holle tonvormige nanoarchitectuur (BP26-M2e nanobarrel). Immunisatie met BP26-M2e nanobarrels induceerde in vivo een sterke M2e-specifieke humorale immuunrespons  dat was veel groter dan dat van een fysisch mengsel van oplosbaar M2e en BP26, met of zonder het gebruik van een aluin-adjuvans.

Een anti- M2e- antilichaam gegenereerd door met BP26-M2e nanobarrel geïmmuniseerde muizen, specifiek gebonden aan met het influenzavirus geïnfecteerde cellen. Bovendien beschermden BP26-M2e-nanobarrels in virale challenge-tests muizen effectief tegen sterfte door influenzavirusinfectie, zelfs zonder het gebruik van een conventioneel adjuvans. Een mechanismestudie onthulde dat zowel M2e-specifieke antilichaamafhankelijke cellulaire cytotoxiciteit als T-celresponsen betrokken zijn bij de vaccineffectiviteit van BP26-M2e nanovaten. Deze bevindingen suggereren dat het op BP26 gebaseerde nanovat dat hier is ontwikkeld een veelzijdig vaccinplatform vertegenwoordigt dat kan worden gebruikt tegen verschillende virale infecties.

Prognostische impression van 18F-FDG PET/CT bij patiënten met agressief B-cellymfoom behandeld met anti-CD19 chimere  antigeenreceptor  T-cellen

Doel van het rapport:  We wilden de rol van 18F-FDG PET/CT evalueren bij het voorspellen van de uitkomst van de patiënt na infusie van chimere antigeenreceptor T (CAR T)-cellen bij agressief B-cellymfoom.

Methoden:  18F-FDG PET/CT-gegevens vóór leukaferese, vóór CAR T-celinfusie en 1 maand (M1) na CAR T-celinfusie, van 72 patiënten werden retrospectief geanalyseerd. SUVmax, totale laesie-glycolyse (TLG), metabool tumorvolume (MTV) en parameters die de tumorkinetiek beschrijven, werden berekend voor elke uitgevoerde 18F-FDG PET/CT. Het doel was om de prognostische waarde van 18F-FDG PET/CT metabole parameters te evalueren voor het voorspellen van progressievrije overleving (PFS) en algehele overleving (OS) na CAR T-celtherapie.

Resultaten: Met betrekking tot PFS bleken [INCREMENT]MTVpre-CAR en [INCREMENT]TLGpre-CAR meer discriminerend te zijn in vergelijking met metabole parameters bij pre-infusie. De mediane PFS bij patiënten met een [INCREMENT]MTVpre-CAR van minder dan 300% was 6,eight maanden (95% betrouwbaarheidsinterval [BI], 2,eight maanden tot niet bereikt) vergeleken met 2,eight maanden (95% BI, 0,9-3,Zero maanden) voor die met een waarde van 300% of meer (P = 0,004). Evenzo was de mediane PFS bij patiënten met [INCREMENT]TLGpre-CAR van minder dan 420% 6,eight maanden (95% BI, 2,eight maanden tot niet bereikt) vergeleken met 2,7 maanden (95% BI, 1,3-3,Zero maanden) voor degenen met een waarde van 420% of meer (P = 0,0148). Met betrekking tot OS waren metabole parameters op M1 sterk geassocieerd met de daaropvolgende uitkomst. SUVmax bij M1 met een afkapwaarde van 14 was de meest voorspellende parameter in multivariate analyse,

Conclusies: De  metabole volumekinetiek van de ziekte vóór infusie van CAR T-cellen lijkt superieur te zijn aan de initiële tumormassa zelf voor het voorspellen van PFS. Voor OS kan SUVmax bij M1 patiënten met verschillende prognoses adequaat scheiden.

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132)

MAB12298-500 0.5
EUR 695.29
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133)

MAB12299-100 0.1
EUR 276.84
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133)

MAB12299-500 0.5
EUR 695.29
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133)

NK1.1 antibody (PE)

61R-1381 100 ug
EUR 211
Description: Mouse monoclonal NK1.1 antibody (PE)

NK1.1 Antibody (PE)

abx228018-100g 100 µg
EUR 62.5

Borrelia Afzelii Antigen

NAT41583-100 0.1
EUR 391.66
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside.

Borrelia Afzelii Antigen

NAT41583-500 0.5
EUR 1176.24
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside.

Borrelia Garinii Antigen

NAT41584-100 0.1
EUR 391.66
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside.

Borrelia Garinii Antigen

NAT41584-500 0.5
EUR 1176.24
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside.

Brucella Abortus Antigen

NAT41599-100 0.1
EUR 391.66
Description: Brucella abortus lysate, produced by fermentation.

Brucella Abortus Antigen

NAT41599-500 0.5
EUR 1176.24
Description: Brucella abortus lysate, produced by fermentation.

Candida Albicans Antigen

NAT41601-100 0.1
EUR 391.66
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components.

Candida Albicans Antigen

NAT41601-500 0.5
EUR 1176.24
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components.

Canine Parvovirus Antigen

NAT41594-100 0.1
EUR 391.66
Description: Canine Parvovirus, produced in CRFK cells.

Canine Coronavirus Antigen

NAT41590-100 0.1
EUR 391.66
Description: Canine Coronavirus produced in A-72 cells.

Feline Calicivirus Antigen

NAT41595-100 0.1
EUR 391.66
Description: Feline Calicivirus produced in FC 3TG cells.

Helicobacter Pylori Antigen

NAT41603-100 0.1
EUR 391.66
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation.

Helicobacter Pylori Antigen

NAT41603-500 0.5
EUR 1176.24
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation.

Campylobacter Jejuni Antigen

NAT41600-100 0.1
EUR 391.66
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE.

Campylobacter Jejuni Antigen

NAT41600-500 0.5
EUR 1176.24
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE.

Chlamydia Trachomatis Antigen

CT022-1000 1.0
EUR 378.9
Description: Chlamydia trachomatis antigens from clarified cell lysate.

Mycoplasma Pneumoniae Antigen

MP901-1000 1.0
EUR 1010.39
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background.

Mycoplasma Pneumoniae Antigen

MP901-200 0.2
EUR 270.46
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background.

Echovirus Antigen, Recombinant

REC31776-100 0.1
EUR 276.84
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus

Echovirus Antigen, Recombinant

REC31776-500 0.5
EUR 1043.56
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus

Neisseria Gonorrhoeae Antigen

NG01-1000 1.0
EUR 378.9
Description: Homogenised lysate of pure bacteria.

Trichomonas Vaginalis Antigen

TV01-1000 1.0
EUR 421
Description: Washed & lysed suspension of whole protozoa

Enterovirus Antigen, Recombinant

REC31772-100 0.1
EUR 276.84
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA.

Enterovirus Antigen, Recombinant

REC31772-500 0.5
EUR 1043.56
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA.

Echinococcus Granulosus Antigen

NAT41602-100 0.1
EUR 391.66
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid.

Echinococcus Granulosus Antigen

NAT41602-500 0.5
EUR 1176.24
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid.

Astrovirus Antigen (Type 1)

AS02-1000 1.0
EUR 1654.65
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells.

Astrovirus Antigen (Type 1)

AS02-200 0.2
EUR 442.69
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells.

Yersinia pestis V antigen

REC32028-100 0.1
EUR 491.53
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product.

Yersinia pestis V antigen

REC32028-500 0.5
EUR 2421.37
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product.

Cytomegalovirus Purified Antigen

CMV-HP-100 0.1
EUR 318.94
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Cytomegalovirus Purified Antigen

CMV-HP-1000 1.0
EUR 2096.06
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Cytomegalovirus Purified Antigen

CMV-HP-500 0.5
EUR 1279.58
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Canine Herpes Virus Antigen

NAT41592-100 0.1
EUR 391.66
Description: Canine Herpes virus, produced in MDCK cells.

Canine Adenovirus 1 Antigen

NAT41587-100 0.1
EUR 391.66
Description: Canine Adenovirus Type 1, produced in A-72 cells.

Canine Adenovirus 2 Antigen

NAT41588-100 0.1
EUR 391.66
Description: Canine Adenovirus Type 2, produced in A-72 cells.

Canine Distemper Virus Antigen

NAT41591-100 0.1
EUR 391.66
Description: Canine Distemper virus, produced in SL-29 cells.

Norovirus GII.4 VP1 Antigen

REC31620-100 0.1
EUR 302.36
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells.

Norovirus GII.4 VP1 Antigen

REC31620-1000 1.0
EUR 1830.71
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells.

Norovirus GII.4 VP1 Antigen

REC31620-500 0.5
EUR 1066.53
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells.

Canine Parainfluenza Virus Antigen

NAT41593-100 0.1
EUR 391.66
Description: Canine Parainfluenza virus antigen, produced in MDCK cells.

Feline Panleukopenia Virus Antigen

NAT41597-100 0.1
EUR 391.66
Description: Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells.

Cytomegalovirus Cell Lysate Antigen

CMV-CL-100 0.1
EUR 223.26
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle.

Cytomegalovirus Cell Lysate Antigen

CMV-CL-1000 1.0
EUR 1422.47
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle.

Herpes Simplex Virus 1 Antigen

HS105-1000 1.0
EUR 1178.79
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 1 Antigen

HS105-200 0.2
EUR 294.7
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 2 Antigen

HS205-1000 1.0
EUR 1178.79
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 2 Antigen

HS205-200 0.2
EUR 294.7
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Feline Viral Rhinotracheitis Antigen

NAT41598-100 0.1
EUR 391.66
Description: Feline Viral Rhinotracheitis (FVR; feline herpes virus, FHV-1) antigen, produced in CRFK cells.

Ross River Virus Recombinant Antigen

REC31969-100 0.1
EUR 757.8
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein.

Ross River Virus Recombinant Antigen

REC31969-500 0.5
EUR 2844.92
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein.

Hepatitis B Virus E Antigen (HBeAg)

REC31677-100 0.1
EUR 456.72
Description: Recombinant Hepititis B Virus E Protein (HBeAg).

Hepatitis B Virus E Antigen (HBeAg)

REC31677-500 0.5
EUR 1941.06
Description: Recombinant Hepititis B Virus E Protein (HBeAg).

Canine Adenovirus 1 and 2 Antigen

NAT41589-100 0.1
EUR 391.66
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells.

Hepatitis B Virus Core Antigen (HBcAg)

REC31689-100 0.1
EUR 456.72
Description: Recombinant Hepititis B Virus Core Protein (HBcAg).

Hepatitis B Virus Core Antigen (HBcAg)

REC31689-500 0.5
EUR 1370.16
Description: Recombinant Hepititis B Virus Core Protein (HBcAg).

Hepatitis C Virus Core Antigen (HCcAg)

REC31693-100 0.1
EUR 484.79
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag.

Hepatitis C Virus Core Antigen (HCcAg)

REC31693-500 0.5
EUR 1455.64
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag.

Herpes Simplex Virus 1 Lysate Antigen

HS104-1000 1.0
EUR 270.46
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate.

Herpes Simplex Virus 2 Lysate Antigen

HS204-1000 1.0
EUR 270.46
Description: A high concentration of HSV-2 particles and proteins from a clarified cell lysate.

Feline Infectious Peritonitis Virus Antigen

NAT41596-100 0.1
EUR 391.66
Description: Feline Infectious Peritonitis virus (FIPV; feline coronavirus) antigen, produced in CRFK cells.

Legionella pneumophila antigen (native extract)

NAT41580-100 0.1
EUR 391.66
Description: Inactivated Legionella pneumophila antigen from culture.

Leptospira Biflexa Antigen (Strain Patoc 1)

NAT41582-100 0.1
EUR 391.66
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture.

Leptospira Biflexa Antigen (Strain Patoc 1)

NAT41582-500 0.5
EUR 1176.24
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture.

NK1.1 Antibody (PE / Cyanine 5)

abx228021-100g 100 µg
EUR 100

NK1.1 Antibody (PE / Cyanine 7)

abx228022-100g 100 µg
EUR 100

NK1.1 Antibody (PE / Cyanine 5.5)

abx228023-100g 100 µg
EUR 100

Streptococcus Pneumoniae Antigen, Native Extract

NAT41604-100 0.1
EUR 391.66
Description: Inactivated Streptococcus pneumoniae antigen from culture.

PE Anti-Mouse CD161/NK1.1 Antibody

DL20028F-100Tests 100Tests
EUR 212
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE Anti-Mouse CD161/NK1.1 Antibody

DL20028F-50Tests 50Tests
EUR 152
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE Anti-Mouse CD161/NK1.1 Antibody

DL20038F-25ug 25μg
EUR 147.5
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE Anti-Mouse CD161/NK1.1 Antibody

DL20038F-50ug 50μg
EUR 200
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

OATA00373-25UG - Mouse NK1.1 Antibody : PE

OATA00373-25UG 25ug
EUR 49

OATA00373-100UG - Mouse NK1.1 Antibody : PE

OATA00373-100UG 100ug
EUR 139

OASB00609-100UG - Mouse NK1.1 Antibody : PE

OASB00609-100UG 0.1mg
EUR 259

OASB00613-200UG - Mouse NK1.1 Antibody : PE

OASB00613-200UG 0.2mg
EUR 369

Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag

REC32027-100 0.1
EUR 491.53
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1)

Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag

REC32027-500 0.5
EUR 2421.37
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1)

Mouse NK-1.1 Antigen Antibody

GWB-A2F1FE 0.025 mg Ask for price

Mouse NK-1.1 Antigen Antibody

GWB-721C59 0.25 mg Ask for price

PE Anti-Mouse CD161/NK1.1 Antibody[PK136]

E-AB-F0987UD-100ug 100ug
EUR 84
Description: FCM

PE Anti-Mouse CD161/NK1.1 Antibody[PK136]

E-AB-F0987UD-25ug 25ug
EUR 30
Description: FCM

PE Anti-Mouse CD161/NK1.1 Antibody[PK136]

E-AB-F0987UD-each each Ask for price
Description: FCM

PE Anti-Mouse CD161/NK1.1 Antibody[PK136]

E-AB-F0987D-100Tests 100Tests
EUR 48
Description: FCM

PE Anti-Mouse CD161/NK1.1 Antibody[PK136]

E-AB-F0987D-100Tests2 100Tests×2
EUR 72
Description: FCM

PE Anti-Mouse CD161/NK1.1 Antibody[PK136]

E-AB-F0987D-50Tests 50Tests
EUR 28
Description: FCM

Mouse NK-1.1 Antigen Antibody (RPE)

GWB-AA27CB 25 TESTS Ask for price

Mouse NK-1.1 Antigen Antibody (RPE)

GWB-BA4361 100 TESTS Ask for price

CD9 Antigen (CD9) Antibody (PE)

abx200078-100tests 100 tests
EUR 543.6

CD9 Antigen (CD9) Antibody (PE)

abx139163-100tests 100 tests
EUR 577.2

CD9 Antigen (CD9) Antibody (PE)

abx140025-01mg 0.1 mg
EUR 444

CD9 Antigen (CD9) Antibody (PE)

abx134465-100Assays 100 Assays
EUR 594

CD9 Antigen (CD9) Antibody (PE)

abx134465-50Assays 50 Assays
EUR 477.6

CD9 Antigen (CD9) Antibody (PE)

abx228758-100g 100 µg
EUR 112.5

CD9 Antigen (CD9) Antibody (PE)

abx270768-1ml 1 ml
EUR 625

CD9 Antigen (CD9) Antibody (PE)

abx270768-200l 200 µl
EUR 525

CD9 Antigen (CD9) Antibody (PE)

abx270797-1ml 1 ml
EUR 625

CD9 Antigen (CD9) Antibody (PE)

abx270797-200l 200 µl
EUR 525

CD9 Antigen (CD9) Antibody (PE)

abx140025-100g 100 µg
EUR 287.5

CD9 Antigen (CD9) Antibody (PE)

abx139163-100l 100 µl
EUR 400

CD9 Antigen (CD9) Antibody (PE)

abx139163-500l 500 µl Ask for price

CD9 Antigen (CD9) Antibody (PE)

abx414859-200l 200 µl
EUR 487.5

NK1.1 antibody

10R-6581 100 ug
EUR 210
Description: Mouse monoclonal NK1.1 antibody

NK1.1 Antibody

abx140071-01mg 0.1 mg
EUR 343.2

NK1.1 Antibody

abx140072-01mg 0.1 mg
EUR 343.2

NK1.1 Antibody

abx228014-100g 100 µg
EUR 118.75

NK1.1 Antibody

abx228015-100g 100 µg
EUR 50

PE/Cyanine5 Anti-Mouse CD161/NK1.1 Antibody

DL20031F-20Tests 20Tests
EUR 152
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine5 Anti-Mouse CD161/NK1.1 Antibody

DL20031F-50Tests 50Tests
EUR 212
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine7 Anti-Mouse CD161/NK1.1 Antibody

DL20032F-20Tests 20Tests
EUR 152
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine7 Anti-Mouse CD161/NK1.1 Antibody

DL20032F-50Tests 50Tests
EUR 212
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine5.5 Anti-Mouse CD161/NK1.1 Antibody

DL20033F-20Tests 20Tests
EUR 152
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine5.5 Anti-Mouse CD161/NK1.1 Antibody

DL20033F-50Tests 50Tests
EUR 212
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine5 Anti-Mouse CD161/NK1.1 Antibody

DL20041F-25ug 25μg
EUR 230
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine5 Anti-Mouse CD161/NK1.1 Antibody

DL20041F-50ug 50μg
EUR 335
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine7 Anti-Mouse CD161/NK1.1 Antibody

DL20042F-25ug 25μg
EUR 222.5
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine7 Anti-Mouse CD161/NK1.1 Antibody

DL20042F-50ug 50μg
EUR 320
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine5.5 Anti-Mouse CD161/NK1.1 Antibody

DL20043F-25ug 25μg
EUR 230
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

PE/Cyanine5.5 Anti-Mouse CD161/NK1.1 Antibody

DL20043F-50ug 50μg
EUR 357.5
Description: NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

CD44 Antigen (CD44) Antibody (PE)

abx200295-100tests 100 tests
EUR 661.2

CD63 Antigen (CD63) Antibody (PE)

abx200428-100tests 100 tests
EUR 543.6

CD44 Antigen (CD44) Antibody (PE)

20-abx200795
  • Ask for price
  • Ask for price
  • 100 ug
  • 25 ug

CD63 Antigen (CD63) Antibody (PE)

abx201086-100tests 100 tests
EUR 661.2

CD44 Antigen (CD44) Antibody (PE)

abx139278-100tests 100 tests
EUR 577.2

CD44 Antigen (CD44) Antibody (PE)

abx139282-100tests 100 tests
EUR 577.2

CD44 Antigen (CD44) Antibody (PE)

abx139286-01mg 0.1 mg
EUR 410.4

CD63 Antigen (CD63) Antibody (PE)

abx139314-100tests 100 tests
EUR 577.2

CD44 Antigen (CD44) Antibody (PE)

abx134410-100Assays 100 Assays
EUR 594

CD44 Antigen (CD44) Antibody (PE)

abx134410-50Assays 50 Assays
EUR 477.6

CD63 Antigen (CD63) Antibody (PE)

abx134470-100Assays 100 Assays
EUR 594

CD63 Antigen (CD63) Antibody (PE)

abx134470-50Assays 50 Assays
EUR 477.6

CD44 Antigen (CD44) Antibody (PE)

abx228364-100g 100 µg
EUR 100

CD44 Antigen (CD44) Antibody (PE)

abx228873-100g 100 µg
EUR 68.75

CD44 Antigen (CD44) Antibody (PE)

abx139278-100l 100 µl
EUR 400

CD44 Antigen (CD44) Antibody (PE)

abx139278-500l 500 µl Ask for price

CD44 Antigen (CD44) Antibody (PE)

abx139282-100l 100 µl
EUR 400

CD44 Antigen (CD44) Antibody (PE)

abx139282-500l 500 µl Ask for price

CD44 Antigen (CD44) Antibody (PE)

abx412740-200l 200 µl
EUR 637.5

CD44 Antigen (CD44) Antibody (PE)

abx415397-200l 200 µl
EUR 512.5

CD44 Antigen (CD44) Antibody (PE)

abx415621-200l 200 µl
EUR 562.5

Mouse NK-1.1 ANTIGEN Antibody (Biotin)

GWB-E9106C 0.025 mg Ask for price

CD180 Antigen (CD180) Antibody (PE)

abx139718-100tests 100 tests
EUR 577.2

CD177 Antigen (CD177) Antibody (PE)

abx140142-100tests 100 tests
EUR 577.2

CD180 Antigen (CD180) Antibody (PE)

abx139718-100g 100 µg
EUR 400

CD209 Antigen (CD209) Antibody (PE)

abx140122-100g 100 µg
EUR 400

CD177 Antigen (CD177) Antibody (PE)

abx140142-100g 100 µg
EUR 400

CD151 Antigen (CD151) Antibody (PE)

abx413447-200l 200 µl
EUR 487.5

CD177 Antigen (CD177) Antibody (PE)

abx413640-200l 200 µl
EUR 575

CD209 Antigen (CD209) Antibody (PE)

abx414034-200l 200 µl
EUR 487.5

OASB00612-100UG - Mouse NK1.1 Antibody : PE/CY7

OASB00612-100UG 0.1mg
EUR 269

OATA00451-25UG - Mouse NK1.1 Antibody : PE-Cy7

OATA00451-25UG 25ug
EUR 99

OATA00451-100UG - Mouse NK1.1 Antibody : PE-Cy7

OATA00451-100UG 100ug
EUR 219

Carcinoembryonic Antigen (CEA) Antibody (PE)

20-abx270895
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 tests
  • 200 tests
  • 25 tests
  • 500 tests
  • 50 tests

Geef een reactie

Het e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *